Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Global cancer statistics

Donald Maxwell Parkin, Paola Pisani, Jacques Ferlay · CA A Cancer Journal for Clinicians · 1999 · 3.4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Cancer statistics, 1999

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text

Medicine, Biostatistics, Oncology +17

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

Medicine, Oncology, Pharmacology +12

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

The Lancet · 1995 · 1.1K citations

Medicine, Oncology, Pharmacology +15